London, United Kingdom

Taherah Kamalati

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taherah Kamalati. Retrieved from https://idiyas.com/inventor/taherah-kamalati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Taherah Kamalati: Innovator in Biotech**

Introduction

Taherah Kamalati is a prominent inventor based in London, GB, recognized for her unique contribution to biotechnology. With a passion for research and innovation, she has made significant strides in her field, particularly through her work at Glaxo Wellcome Inc.

Latest Patents

Taherah holds one patent, which is centered around the BRK protein tyrosine kinase and its encoding nucleic acid. This patent reflects her dedication to advancing our understanding of protein interactions and their implications in various biological processes.

Career Highlights

Throughout her career, Taherah has established herself as a leading figure in her area of expertise. Her tenure at Glaxo Wellcome Inc. has been marked by a commitment to innovation and excellence, contributing to important breakthroughs in healthcare and technology.

Collaborations

In her professional journey, Taherah has collaborated with notable colleagues, including Barry Austin Gusterson and Mark Roger Crompton. These partnerships have fostered a rich environment for research and development, enabling diverse perspectives and creative solutions to emerge.

Conclusion

Taherah Kamalati stands as an inspiring figure in the world of biotechnology. Her pioneering efforts and collaborations exemplify the spirit of innovation, paving the way for future advancements in the field. With her ongoing commitment to research and development, she continues to influence the landscape of biotechnology significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…